Pfizer (PFE) Selling, General & Administrative (2009 - 2026)
Pfizer's Selling, General & Administrative was $3.41 billion in Q2 2026, down 0.1% from $3.42 billion a year earlier but up 15.2% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Selling, General & Administrative (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pfizer's Selling, General & Administrative was $13.72 billion through Jun 28, 2026, down 1.7% year-over-year; for FY2025, it came in at $13.79 billion, down 6.4% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 3.5% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $14.73 billion in FY2024 (-0.3%), $14.77 billion in FY2023 (+8.0%), $13.68 billion in FY2022 (+7.7%) and $12.7 billion in FY2021 (+9.5%).
- Quarterly Selling, General & Administrative has moved between $2.59 billion (Q1 2022) and $4.65 billion (Q4 2022) over five years.
- Compared with a year earlier, Selling, General & Administrative has declined for seven straight quarters, with an average decline of 5.0% over the last seven quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2023 (growth of 31.8%); the worst was Q1 2025 (a decline of 13.3%).
- Per Business Quant data, PFE's Selling, General & Administrative in the three quarters before Q2 2026 was $2.96 billion (Q1 2026), $4.16 billion (Q4 2025) and $3.19 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 1.83 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 3.41 Bn |
| Mar 29, 2026 | 2.96 Bn |
| Dec 31, 2025 | 4.16 Bn |
| Sep 28, 2025 | 3.19 Bn |
| Jun 29, 2025 | 3.42 Bn |
| Mar 30, 2025 | 3.03 Bn |
| Dec 31, 2024 | 4.27 Bn |
| Sep 29, 2024 | 3.24 Bn |
| Jun 30, 2024 | 3.72 Bn |
| Mar 31, 2024 | 3.50 Bn |
| Dec 31, 2023 | 4.58 Bn |
| Jul 2, 2023 | 3.50 Bn |
| Apr 2, 2023 | 3.42 Bn |
| Dec 31, 2022 | 4.65 Bn |
| Jul 3, 2022 | 3.05 Bn |
| Apr 3, 2022 | 2.59 Bn |
| Dec 31, 2021 | 4.10 Bn |
| Oct 3, 2021 | 2.90 Bn |
| Jul 4, 2021 | 2.92 Bn |
| Apr 4, 2021 | 2.78 Bn |
API Access
Pfizer Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();